Sage Journals: Discover world-class research

Abstract

Objective

To assess the added value of caregiver-mediated exercises combined with telerehabilitation in addition to usual care compared to usual care alone on the self-reported mobility outcome after subacute stroke.

Design

Multicentre, observer-blinded, parallel randomised controlled trial. An off-site researcher allocated treatments using minimisation.

Setting

Four rehabilitation centres in the Netherlands.

Participants

Forty-one patient–caregiver dyads within 3 months poststroke.

Intervention

Eight-week blended care program with caregiver-mediated mobility exercises for 2.5 h per week supported by telerehabilitation and four face-to-face sessions in addition to usual care.

Main measures

Self-reported mobility domain of the Stroke Impact Scale postintervention. Secondary outcomes were functional outcome, dyads’ psychosocial wellbeing, care transition to the community postintervention and after 6 months.

Results

Forty-one dyads (21 intervention, 20 control) were randomised, and 37 (N = 18; N = 19) were analysed following intention-to-treat. The Stroke Impact Scale mobility was not significantly different between groups postintervention (B 0.8, 95% CI –6.8–8.5, p = 0.826). The secondary outcomes, namely, (a) caregivers’ quality of life postintervention (p = 0.013), (b) caregivers’ symptoms of depression postintervention (p = 0.025), and (c) independence in leisurely activities at 6 months (p = 0.024), showed significant benefits in favour of caregiver-mediated exercises with telerehabilitation. A significant difference favouring controls was found in self-reported muscle strength at 6 months (p = 0.002).

Conclusions

Caregiver-mediated exercises combined with telerehabilitation yielded no differential effect on our primary outcome self-reported mobility. Although the trial is underpowered, current findings are in line with previous trials. Future studies should further explore beneficial effects of caregiver involvement in stroke rehabilitation targeting psychosocial wellbeing.

Keywords

stroke caregivers telerehabilitation exercise walking randomised controlled trial

Introduction

Recovery of independent mobility (e.g. walking and maintaining balance) is a top priority of patients poststroke.¹ In addition, independent mobility determines to a great extent the ability to return home² and level of dependence on informal caregivers. It is estimated that approximately 75% of stroke survivors achieve independent mobility.³ However, a risk of mobility deterioration exists when professional support tapers off.^4,5

Intensive, repetitive task training promotes recovery of mobility and independence in ADL in the first 6 months poststroke^6,7 and is recommended by clinical guidelines worldwide. Although the optimal dose remains unclear, the evidence suggests that more is better.⁸ The recently updated National Institute for Health and Care Excellence (NICE) guideline for stroke in the United Kingdom recommends at least 3 h of individualised motor/functional therapy a day.⁹ Unfortunately, patients often do not receive recommended amounts of training as a result of low staffing levels and time spent in non-patient activities.¹⁰

Training of patient-caregivers dyads to perform task-specific exercises together, i.e. caregiver-mediated exercises, has the potential to augment training without increasing costs.¹¹ In this trial, a dyad refers to a patient and informal caregiver pair. Blended care, i.e. combining face-to-face support with telerehabilitation, may be a promising approach to provide tailored support to dyads and facilitate the transition to self-management at home.¹² Moreover, informal caregivers can provide sustained support after discharge and promote continued activity in the community.

The primary objective of this randomised controlled trial was to assess the added value of caregiver-mediated exercises combined with telerehabilitation in addition to usual care after subacute stroke on patients’ self-reported mobility outcome when compared with usual care alone. Secondary objectives were to assess the differential effects on patients’ functional outcome, dyads’ psychosocial wellbeing and on the care transition in terms of length of stay and preparedness for discharge.

Methods

We conducted a multicentre, observer-blinded randomised controlled trial with two parallel groups (trial registration NTR7664, 11 December 2018). The study protocol with the acronym Allied Rehabilitation using caregiver-Mediated exercises combined with telerehabilitation for Stroke (ARMed4Stroke) was extensively described and published previously.¹³ No protocol changes were made after trial commencement, and no protocol violations were found during monitoring visits. The Medical Ethics Review Committee of VU Medical Centre approved the study protocol on 30 April 2019 (2019.081 — NL67357.029.18), and all participants gave written informed consent. Recruitment started in September 2019 and ended in September 2022, with the last follow-up measurement in January 2023. The current report of results follows the CONSORT statement.¹⁴

Patients and caregivers were recruited from four rehabilitation centres in the Netherlands during in- or outpatient care: (a) Reade Centre for Rehabilitation and Rheumatology, Amsterdam; (b) Roessingh, Centre for Rehabilitation, Enschede; (c) Sint Maartenskliniek, Nijmegen; and (d) Vogellanden, Zwolle. Eligibility was determined in the first week of admission by a rehabilitation physician or physiotherapist. Inclusion criteria were as follows: aged ≥18 years; willing to participate and able to understand Dutch on a sufficient level to understand instructions; complete self-reported questionnaires; and provide written informed consent. Additional inclusion criteria for patients were ≤3 months poststroke according to the WHO definition¹⁵ excluding subarachnoid haemorrhage, living independently pre-stroke, planned to be discharged home or living at home, able to follow instructions (Montreal Cognitive Assessment >21) and willing and able to appoint a caregiver. Caregivers were defined as persons close to the patient (e.g. partner, family and friend) who were not practicing healthcare professionals nor were they paid for their efforts. Caregivers were eligible if they were mentally and physically able to support the patient, as determined by a trained physiotherapist during an intake exercise session. Exclusion criteria for both were a serious comorbidity that interfered with the intervention (e.g. lower extremity fracture) or not being medically stable. After baseline assessment by a blinded observer (MM), an off-site researcher (EW) randomly allocated eligible dyads to the Armed4Stroke intervention in addition to usual care or to usual care alone using an online randomisation module with a minimisation algorithm. Covariates in the minimisation were as follows: (a) centre; (b) inpatient vs outpatient; (c) age ≥70 vs <70; and (d) functional ambulation categories <5 vs 5. The off-site researcher informed the physiotherapist about the assigned intervention. Physiotherapists and dyads could not be blinded to treatment allocation.

The Armed4Stroke intervention was an 8-week progressive, task-specific exercise program focused on mobility in addition to usual care after subacute stroke. Mobility training was supervised by an informal caregiver, supported using blended care with a minimum of four face-to-face sessions scheduled every other week and asynchronous support via the online telerehabilitation platform Telerevalidatie.nl.¹⁶ The physiotherapist composed a tailor-made exercise program in face-to-face consultation with dyads. Dyads were asked to perform exercises together for a minimum of 5 × 30 min per week and were encouraged to train outside of usual training hours and in weekends. During caregiver-mediated exercises, dyads had access to their tailored exercise program with exercise videos, personal instructions, mobility milestones and a messaging environment for asynchronous consultation via the telerehabilitation platform. During face-to-face sessions, patients and caregivers were trained and educated; treatment fidelity was discussed; barriers or facilitators were addressed; progress was evaluated; novel goals were identified; and the exercise program was modified accordingly.

Patients in both study arms received usual mobility exercise therapy following guidelines from the Royal Dutch Society for Physical Therapy.¹⁷ Multidisciplinary teams and supporting staff were instructed that content, frequency, and duration of regular therapies should be scheduled as usual in both arms. Patients in the control group did not have access to the Armed4Stroke module on the telerehabilitation platform, and no explicit attention was given to caregiver involvement. All participants kept an 8-week diary to monitor compliance, fall incidents and estimate treatment contrast. Participants reported daily mobility-related exercise minutes with an informal caregiver, with a nurse, in therapy and self-directed exercise time. In addition, telerehabilitation use and fall incidents were recorded weekly.

Outcomes were assessed by a blinded observer at baseline (≤3 months poststroke), 8 weeks (postintervention) and 6 months follow-up. The primary outcome was the self-reported mobility domain of the Stroke Impact Scale 3.0 after 8 weeks. The mobility domain consists of nine questions about perceived ability to maintain balance, make transfers, walk and climb stairs. Questions are rated on a 5-point Likert scale, and a domain score (0–100) is calculated. The Stroke Impact Scale has excellent psychometric properties.¹⁸ Secondary outcome measures were described in our study protocol, including references.¹³ Secondary outcomes to establish effects on patients’ functional outcome were the other domains of the Stroke Impact Scale, Rivermead Mobility Index, Functional Ambulation Category, 6 min walking distance, 5 m comfortable walking speed, Motricity Index Leg Score, Berg Balance Scale, Nottingham Extended ADL Scale, Community Ambulation Questionnaire and modified Rankin Scale at 8 weeks and 6 months follow-up; and the mobility domain of the Stroke Impact Scale at 6 months. Differential effects in dyads’ psychosocial wellbeing were evaluated at 8 weeks and 6 months follow-up using the Stroke Self-efficacy Questionnaire and EuroQol-5D for patients, modified Caregiver Strain Index, Care-related Quality of Life Instrument (seven dimensions and Visual Analogue Scale) for caregivers, General Self-efficacy Scale, Hospital Anxiety and Depression Scale, PROMIS Computer Adaptive Tests for anxiety and depression, Fatigue Severity Scale and the general functioning subscale of the McMaster Family Assessment Device for both patients and caregivers. Differential effects in the care transition were evaluated at 8 weeks and 6 months follow-up using the Transition Preparedness Scale for patients and Preparedness for Caregiving Scale for caregivers and using length of stay defined as the number of days between hospital admission and discharge home.

Statistical Analyses

Success of observer-blinding was tested by comparing actual with guessed allocation using Cohen's κ statistic. Baseline differences between groups were evaluated using Chi-squared tests, independent samples t-test or non-parametric Mann–Whitney U tests, where appropriate. Treatment effects were evaluated according to intention-to-treat and compared between groups at different time points using a linear mixed model for continuous outcomes and generalised estimating equations for ordinal outcomes. Differences in the care transition were only analysed in participants recruited during inpatient rehabilitation. Group allocation, time, a group–time interaction term and baseline values of the dependent were included as covariates. All hypotheses were tested using a two-tailed significance level alpha of 0.05. Data were analysed using IBM SPSS Statistics version 28. Sample size calculation showed that 72 dyads were required to achieve sufficient statistical power (80%) to detect a significant between-group difference of 10 points (10%) on the mobility domain of the Stroke Impact Scale (mean 79.4, SD 14) using a two-tailed significance level alpha of 0.05, including a 20% drop-out rate.¹³ Due to the unexpected halt of recruitment in March 2020 and the subsequent slowdown of recruitment after restarting the trial during the COVID-19 pandemic, an unplanned futility analysis of the primary outcome was performed when sources of funding ended in September 2022. A conditional power of 20% was used to establish futility. The adjusted p-value for the efficacy analysis was based on 41 patients of the required 72 patients. Using the Lan–DeMets alpha spending function for the Pocock boundary, the adjusted p-value was equal to 0.035.¹⁹

Results

A total of 41 dyads were recruited (Figure 1: CONSORT flowchart) and randomised to the Armed4Stroke group (N = 21) or usual care alone (N = 20). Low agreement was observed between blinded guesses from the assessor and actual treatment allocation (κ=0.219, p = 0.161), indicating successful blinding. Self-reported mobility-related exercise minutes (caregiver-mediated, self-directed, in therapy and with a nurse) during 8 weeks are reported in Table 1. Median caregiver-mediated exercise minutes in the Armed4Stroke group slightly exceeded the intended dose of 1200 min, and a significant treatment contrast was observed (p < 0.006). No significant contrast was observed in the total mobility-related exercise time (p = 0.221) with a median of 3875 min (IQR 2185–6605) in the usual care group compared to 5010 min (IQR 4060–6120) in the Armed4Stroke group. In the usual care group, five falls were reported compared to four falls in the Armed4Stroke group (p = 0.703).

Figure 1.

CONSORT 2010 flow diagram.

Table 1.

Total self-reported exercise minutes during 8 weeks.

Self-reported exercise minutes	Usual care median (IQR)	Armed4Stroke median (IQR)	p-Value
With a therapist	1445 (740–2633)	1420 (720–2250)	0.778
Self-directed	1005 (873–1880)	1950 (750–2690)	0.540
With a nurse	30 (0–295)	0 (0–20)	0.101
Caregiver-mediated	435 (235–1145)	1260 (930–1980)	0.006*

IQR = interquartile range. *p < 0.05.

Baseline characteristics are presented in Table 2. Patients had an average age of 62 years (SD 10.2), while the caregivers’ mean age was 59 years (SD 11.5). Approximately 56% of our patients were male, and almost 15% of them were not born in the Netherlands. Most patients (90.2%) were recruited during inpatient rehabilitation, participated with their partner (95.1%) and were on average 56 days (SD 16.6) poststroke. A significant between-group difference was observed in stroke classification (p = 0.036), with a higher proportion of lacunar strokes in the Armed4Stroke group. No significant baseline differences were observed in our primary outcome measure (MD −9.91, 95% CI −22.77–2.95, p = 0.127) or secondary outcome measures.

Table 2.

Baseline characteristics.

	Control (N = 20)	Armed4Stroke (N = 21)	p-Value
Patient
Sex, female/male	8/12	10/11	0.623
Mean age (SD), years	63.0 (8.9)	61.3 (11.5)	0.608
Education, low/high¹	7/13	9/12	0.606
Country of birth, Dutch/other	17/3	18/3	1.000
Living arrangement, alone/together	1/19	1/20	1.000
Working before stroke, yes/no	9/11	15/6	0.086
CIRS (0–52), median (IQR)	4.0 (2.0–5.0)	2.0 (1.0–4.0)	0.164
Rehabilitation phase, in/outpatient	17/3	20/1	0.343
Mean time poststroke (SD), days	56.8 (17.1)	55.2 (16.6)	0.775
Stroke type, haemorrhagic/ischaemic	6/14	7/14	0.819
Stroke location, right hemisphere/left hemisphere/brainstem/cerebellum	10/7/2/1	18/2/1/0	0.051
Recurrent stroke, yes/no	1/19	1/20	1.000
Aphasia, yes/no	1/19	1/20	1.000
Hemianopia, yes/no	3/17	0/21	0.107
Bamford, LACS*/PACS/POCS/TACS	10/6/1/3	18/3/0/0	0.036*
MoCA (0–30), mean (SD)	26.3 (2.3)	25.6 (2.0)	0.314
Caregiver
Sex, female/male	10/10	11/10	0.879
Mean age (SD), years	60.2 (12.2)	58.4 (10.9)	0.624
Education, low/high¹	9/11	9/11	1.000
Country of birth, Dutch/other	19/1	16/4	0.184
Relationship to patient, partner/other	19/1	18/2	0.606
Living together, yes/no	20/0	19/2	0.488
Median duration relationship (IQR), years	39.5 (26.3–45.0)	35.5 (22.0–43.8)	0.492
Working (before stroke), yes/no	10/10	16/5	0.082
CIRS (0–52), median (IQR)	0.5 (0.0–2.0)	2.0 (0.0–4.0)	0.247

SD = standard deviation; IQR = interquartile range; CIRS = cumulative illness rating scale; LACS = lacunar stroke; PACS = partial anterior circulation stroke; POCS = posterior circulation syndrome; TACS = total anterior circulation stroke; MoCA = Montreal cognitive assessment.

Education: low = none/primary school/secondary school/intermediate vocational education; high = higher vocational education/college/university. *p < 0.05.

The absolute mean values (SD) of our primary and secondary outcomes at different time points and between-group results of the linear mixed model and generalised estimating equations analyses corrected for baseline score are presented in Table 3. No significant differences were observed between groups for the primary outcome measure, Stroke Impact Scale mobility, after 8 weeks (B 0.8, 95% CI −6.8–8.5, p = 0.826). Conditional power was calculated, and futility (<0.2) was established (0.066). We concluded that extending recruitment by applying for novel funding would not result in efficacy, and the project team decided to stop the trial.

Table 3.

Results of the intention-to-treat analyses corrected for the baseline score.

Outcome measures	Control (N = 20)			Intervention (N = 21)			Between-group effect sizes, T1		Between-group effect sizes, T2
Outcome measures	T0	T1	T2	T0	T1	T2	B (95% CI)	p-Value	B (95% CI)	p-Value
Primary outcome measure
SIS mobility (0–100)	61.3 (21.9)	82.7 (15.6)	85.5 (16.7)	71.2 (18.2)	86.0 (13.1)	85.1 (12.0)	0.8 (−6.8–8.5)	0.826	3.6 (−4.1–11.3)	0.354
Secondary outcome measures
SIS strength (0–100)*	41.8 (23.1)	52.4 (20.7)	62.5 (23.1)	44.6 (21.6)	52.6 (22.5)	51.0 (26.6)	5.4 (−4.7–15.4)	0.289	16.2 (6.1–26.4)	0.002
SIS memory (0–100)	85.9 (14.9)	91.1 (10.2)	90.1 (11.3)	85.5 (14.9)	88.0 (14.2)	88.2 (15.7)	2.5 (−4.0–9.1)	0.444	1.2 (−5.5–7.8)	0.725
SIS emotion (0–100)	60.7 (7.1)	60.5 (6.9)	68.3 (12.7)	64.8 (10.0)	63.3 (8.0)	64.0 (10.1)	−1.1 (−7.3–5.0)	0.712	6.0 (−0.2–12.3)	0.059
SIS communication (0–100)	92.9 (12.8)	93.7 (9.3)	94.5 (6.6)	92.3 (9.1)	91.9 (10.3)	91.2 (10.8)	1.3 (−3.0–5.6)	0.554	2.7 (−1.7–7.0)	0.224
SIS ADL (0–100)	53.4 (15.1)	64.0 (15.3)	71.2 (17.0)	60.1 (17.1)	72.4 (14.9)	79.5 (12.5)	−4.5 (−12.5–3.6)	0.272	−5.1 (−13.3–3.0)	0.210
SIS hand (0–100)	27.1 (32.5)	37.5 (37.0)	55.0 (34.8)	31.9 (36.1)	55.5 (33.7)	62.4 (33.5)	−13.0 (−29.4–3.4)	0.119	−3.2 (−19.8–13.4)	0.704
SIS participation (0–100)	46.4 (24.5)	58.9 (12.9)	63.4 (21.7)	42.1 (23.1)	61.8 (18.8)	68.8 (20.8)	−4.2 (−16.2–7.9)	0.492	−6.9 (−19.1–5.3)	0.266
SIS recovery (0–100)	41.4 (16.4)	53.5 (16.9)	55.6 (21.4)	44.9 (17.5)	57.3 (18.0)	66.5 (14.6)	−0.5 (−9.5–8.5)	0.911	−7.9 (−17.0–1.2)	0.087
SIS physical (0–100)	49.6 (17.4)	63.6 (16.3)	71.6 (17.5)	56.4 (16.1)	70.9 (13.8)	74.2 (13.3)	−2.0 (−8.8–4.8)	0.554	1.9 (−5.0–8.7)	0.588
RMI (0–15)	9.3 (3.8)	12.3 (2.8)	12.9 (2.4)	9.6 (3.3)	12.8 (2.0)	13.6 (1.2)	−0.4 (−1.5–0.7)	0.493	−0.6 (−1.8–0.5)	0.253
FAC (0–5)	3.6 (1.3)	4.6 (0.9)	4.9 (0.5)	3.6 (1.0)	4.8 (0.4)	5.0 (0.2)	−1.9 (−4.1–0.3)	0.091	−1.1 (−4.8–2.6)	0.556
CAQ (0–3)	0.8 (1.2)	2.1 (1.2)	2.1 (1.3)	0.6 (1.1)	2.1 (1.2)	2.5 (1.0)	0.1 (−1.2–1.4)	0.860	−1.1 (−2.6–0.5)	0.174
5MWT speed, m/s	0.56 (0.33)	0.89 (0.37)	0.97 (0.47)	0.55 (0.25)	0.90 (0.29)	0.95 (0.33)	−0.1 (−0.2–0.1)	0.474	0.0 (−0.2–0.2)	0.903
6MWT distance, meters	231.9 (133.9)	329.7 (135.4)	343.0 (136.5)	198.4 (106.3)	316.1 (117.9)	329.6 (125.8)	−13.3 (−76.1–49.5)	0.669	−3.4 (−67.6–60.8)	0.915
BBS (0–56)	41.4 (13.9)	51.8 (5.0)	52.7 (4.9)	43.7 (11.8)	52.0 (4.6)	53.4 (3.8)	−0.4 (−1.9–1.1)	0.608	−0.6 (−2.2–1.0)	0.478
MI leg (0–100)	55.3 (19.6)	66.4 (19.3)	68.5 (22.3)	50.9 (17.1)	67.7 (23.3)	67.2 (24.9)	−6.7 (−15.8–2.3)	0.141	−1.6 (−11.0–7.8)	0.732
NEADL mobility (0–6)	1.3 (1.8)	3.9 (1.7)	4.1 (2.0)	1.7 (1.7)	3.9 (1.8)	4.9 (1.0)	0.1 (−1.0–1.1)	0.890	−0.7 (−1.7–0.40	0.188
NEADL kitchen (0–5)	2.0 (1.6)	3.8 (1.4)	4.2 (1.0)	2.5 (1.7)	4.4 (1.2)	4.4 (1.0)	−0.3 (−1.1–0.4)	0.349	0.0 (−0.7–0.7)	0.969
NEADL household (0–5)	0.8 (1.1)	2.1 (1.6)	2.6 (1.8)	1.1 (1.3)	2.5 (1.5)	3.3 (1.3)	−0.2 (−1.2–0.8)	0.668	−0.4 (−1.4–0.6)	0.399
NEADL leisure (0–6)*	2.9 (0.6)	3.4 (0.7)	4.0 (0.9)	2.5 (1.0)	3.7 (0.7)	4.4 (1.0)	−0.5 (−1.1–0.0)	0.052	−0.6 (−1.2– −0.1)	0.024
mRS (0–5)	3.3 (0.7)	2.4 (0.7)	1.8 (0.9)	3.2 (0.6)	2.1 (0.7)	1.5 (0.7)	1.0 (−0.1–2.2)	0.068	1.1 (−0.5–2.7)	0.189
TPS (0–32)	17.8 (7.8)	21.3 (7.5)	22.9 (6.4)	17.2 (7.2)	20.2 (6.3)	20.6 (6.8)	1.0 (−2.7–4.7)	0.596	2.0 (−1.8–5.8)	0.306
SSEQ activity (0–80)	45.7 (15.3)	58.8 (14.8)	65.5 (14.1)	47.3 (19.3)	58.2 (12.1)	63.8 (10.6)	1.1 (−6.0–8.3)	0.749	1.5 (−5.7–8.7)	0.678
SSEQ self-management (0–50)	35.7 (6.7)	36.1 (7.8)	36.3 (8.6)	34.1 (8.6)	34.9 (8.5)	35.8 (9.4)	0.3 (−4.1–4.8)	0.887	−0.2 (−4.7–4.4)	0.944
GSES (10–40)	32.1 (4.6)	32.8 (6.4)	34.7 (4.9)	32.8 (6.4)	32.9 (5.0)	33.1 (4.8)	1.1 (−1.8–4.0)	0.452	2.8 (−0.2–5.7)	0.064
EQ5D (0–10)	3.3 (1.5)	3.0 (1.5)	2.1 (1.4)	3.5 (1.5)	2.8 (1.5)	2.6 (1.6)	0.3 (−0.5–1.2)	0.442	−0.3 (−1.2–0.5)	0.462
EQ5D-VAS (0–100)	57.3 (17.3)	63.4 (14.3)	73.4 (17.1)	56.3 (19.9)	64.3 (16.5)	74.1 (15.6)	0.6 (−8.4–9.7)	0.892	0.1 (−9.0–9.3)	0.975
FSS mean (1–7)	3.8 (1.1)	3.6 (1.2)	3.8 (1.4)	3.9 (1.4)	4.0 (1.5)	4.2 (1.7)	−0.3 (−1.1–0.5)	0.491	−0.2 (−1.0–0.6)	0.580
FAD-GF mean (1–4)	1.5 (0.5)	1.4 (0.4)	1.5 (0.4)	1.6 (0.5)	1.5 (0.5)	1.6 (0.6)	−0.0 (−0.3–0.2)	0.716	−0.1 (−0.3–0.2)	0.648
HADS anxiety (0–21)	4.0 (3.7)	3.8 (3.7)	3.4 (1.9)	3.9 (2.8)	3.9 (3.0)	3.6 (3.4)	−0.6 (−2.3–1.0)	0.444	−0.5 (−2.1–1.2)	0.576
HADS depression (0–21)	4.2 (2.9)	3.8 (2.6)	3.9 (3.5)	4.8 (4.0)	3.8 (3.4)	3.7 (3.3)	0.5 (−1.3–2.3)	0.580	0.8 (−1.0–2.6)	0.379
PROMIS anxiety (-∞-∞)	51.5 (6.8)	52.0 (7.5)	51.4 (6.2)	52.5 (6.4)	51.8 (6.7)	50.6 (8.2)	1.1 (−2.6–4.7)	0.558	1.5 (−2.0–5.1)	0.389
PROMIS depression (-∞-∞)	51.2 (6.9)	49.9 (7.0)	53.5 (6.6)	49.7 (6.9)	50.0 (7.1)	50.8 (7.8)	−0.4 (−41–3.2)	0.813	1.6 (−2.1–5.2)	0.388
Secondary outcome measures — caregiver
CSI (0–13)	5.5 (2.1)	5.8 (2.8)	4.9 (3.5)	5.8 (2.8)	6.1 (2.1)	4.7 (2.5)	−0.4 (−1.9–1.1)	0.604	0.1 (−1.5–1.7)	0.890
CarerQoL-7D (0–14)*	11.7 (2.0)	9.9 (2.1)	11.4 (1.7)	11.7 (2.2)	11.4 (1.5)	11.1 (2.6)	−1.4 (−2.5– −0.3)	0.013	0.1 (−1.0–1.2)	0.866
CarerQoL-VAS (0–10)*	7.5 (1.1)	6.7 (1.4)	7.6 (0.9)	7.1 (1.1)	7.5 (0.8)	7.4 (1.3)	−0.7 (−1.3–0.0)	0.042	0.1 (−0.5–0.8)	0.697
HADS anxiety (0–21)	3.6 (2.2)	3.7 (3.7)	3.6 (2.5)	4.2 (2.7)	4.0 (2.5)	4.1 (3.0)	0.4 (−1.6–2.3)	0.714	0.1 (−1.9–2.1)	0.929
HADS depression (0–21)*	1.9 (2.6)	3.2 (2.9)	2.5 (2.4)	3.5 (3.5)	2.6 (3.0)	2.6 (2.4)	1.8 (0.2–3.4)	0.025	0.9 (−0.7–2.5)	0.245
PROMIS anxiety (-∞-∞)	52.3 (5.7)	51.7 (6.1)	51.9 (4.5)	51.1 (5.5)	51.2 (3.9)	51.6 (5.3)	0.0 (−3.0–3.1)	0.984	−0.3 (−3.5–2.8)	0.825
PROMIS depression (-∞-∞)	50.2 (5.3)	49.2 (5.6)	51.0 (4.9)	50.7 (5.6)	50.1 (4.4)	51.7 (5.4)	0.2 (−2.7–3.1)	0.894	−0.3 (−3.3–2.7)	0.866
PCS (0–32)	18.3 (5.5)	18.9 (8.0)	19.2 (6.3)	18.9 (5.0)	17.9 (4.6)	17.4 (6.9)	1.6 (−2.2–5.4)	0.396	2.7 (−1.1–6.5)	0.156
FSS mean (1–7)	2.5 (1.0)	3.2 (1.2)	2.8 (1.0)	2.9 (1.2)	3.3 (1.1)	2.6 (1.6)	0.4 (−0.3–1.0)	0.259	0.5 (−0.2–1.2)	0.155
FAD mean (1–4)	1.5 (0.4)	1.6 (0.4)	1.5 (0.4)	1.4 (0.4)	1.5 (0.4)	1.5 (0.4)	0.1 (−0.1–0.4)	0.270	0.0 (−0.2–0.3)	0.935
GSES (10–40)	33.5 (4.5)	34.3 (3.8)	33.5 (3.7)	33.6 (5.2)	35.0 (4.0)	34.5 (3.8)	−0.3 (−2.5–1.9)	0.777	−0.5 (−2.8–1.7)	0.632

SD = standard deviation; B = beta; CI = confidence interval; SIS = Stroke Impact Scale; RMI = Rivermead Mobility Index; FAC = functional ambulation categories; 5MWT = 5-m walk test; 6MWT = 6-min walk test; BBS = Berg Balance Scale; MI = Motricity Index; NEADL = Nottingham Extended ADL; mRS = modified Ranking Scale; TPS = Transition Preparedness Scale; SSEQ = Stroke Self-efficacy Questionnaire; GSES = General Self-efficacy Scale; EQ5D = EuroQol 5 Dimensions; VAS = Visual Analogue Scale; FSS = Fatigue Severity Scale; FAD-GF = Family Assessment Device-General Functioning; HADS = Hospital Anxiety and Depression Scale; PROMIS = Patient-reported Outcome Measurement Information System; CSI = Caregiver Strain Index; CarerQoL = Care-related Quality of Life Instrument; PCS = Preparedness for Caregiving Scale. *p < 0.05.

After 8 weeks, no significant differential effects were observed in patients’ functional outcome or psychosocial wellbeing. We did observe significant beneficial effects in caregivers’ psychosocial wellbeing, following the Care-related Quality of Life Instrument (seven-dimension score p = 0.013 and Visual Analogue Scale p = 0.042) and depression domain of the Hospital Anxiety and Depression Scale (p = 0.025) after 8 weeks. After 6 months of follow-up, we observed a significant between-group difference in terms of the functional outcome on the leisure domain of the Nottingham Extended ADL scale (p = 0.024) in favour of the Armed4Stroke group and on the strength domain of the Stroke Impact Scale (p = 0.002) favouring the control group. No significant beneficial effects were observed in psychosocial wellbeing after 6 months. Within the subgroup of patients recruited from an inpatient setting, no significant differential effects were established in the care transition. A non-significant difference was observed between groups in the length of stay with a mean stay of 91.0 days (SD 29.0) in the usual care group compared to 83.9 days (SD 23.4) in the Armed4Stroke group (MD 7.06; SE 8.98; 95% CI −11.24–25.35; p = 0.438).

Discussion

The main finding of this multicentre, randomised controlled trial is that our intervention yielded no significant differential effect on the primary outcome, patients’ self-reported mobility following the Stroke Impact Scale after 8 weeks, when compared to usual care alone. Within the subgroup of patients recruited during inpatient care, we found no clear benefits with respect to the care transition to the community. We did observe an added value on patients’ independence in leisurely activities after 6 months and caregivers’ psychosocial wellbeing at 8 weeks in line with previous trials.^20–22

Caregiver-mediated exercises combined with telerehabilitation in addition to usual care did not result in an improvement of patients’ self-reported mobility after 8 weeks when compared with usual care nor after 6 months follow-up. Despite the lower number of subjects recruited than foreseen in the study protocol, we found no trend in the futility analysis. The neutrality of findings is supported by the absence of beneficial effects on secondary functional outcome measures, with the exception of independence in leisurely activities at 6 months. These findings are in line with several other caregiver-mediated exercise studies poststroke,^20,21,23 but runs contrary to another small sampled trial by Galvin et al.²⁴ The effect estimates reported by Galvin et al., however, were not adjusted for baseline imbalances and may be overly optimistic. Our hypotheses were based on beneficial effects of augmenting task-specific training. Although it should be acknowledged that estimations of treatment contrast were based on self-report and not on the actual number of repetitions of task-specific training, the exercise time did not differ significantly between groups, which may explain the neutral results. Cluster randomisation could prevent issues of contamination in future studies. In addition, informal caregivers may already provide training in usual care. To achieve sufficient contrast, a higher dose may be required, or our protocol may be complemented with other resource-efficient strategies, such as self-directed,²⁵ circuit-class²⁶ or peer-to-peer training. Finally, future trials should consider sensors to objectively measure activity and record both scheduled and active therapy time.

We additionally hypothesised that active involvement of caregivers and providing blended care support would empower dyads and improve psychosocial wellbeing as well as the care transition to the community.¹³ We found no beneficial effects on patients’ psychosocial wellbeing; however, our study yielded positive differential effects in caregivers’ wellbeing, namely, improved quality of life and reduced depressive symptoms after 8 weeks. Despite the multiple-comparison problem for these secondary outcomes, the results are in line with previous caregiver-mediated exercises trials poststroke.^20,21 Moreover, the majority (70%) of studies investigating mobility-directed, caregiver-mediated exercises reported improved caregiver outcomes in terms of psychological wellbeing or reduced burden.²⁷ Improved psychosocial wellbeing of caregivers may be linked to their active involvement in rehabilitation care, resulting in more insight and knowledge, improved skills to support the patient, feelings of empowerment and reduced uncertainty. Future caregiver-mediated exercise studies poststroke should explore more in-depth how caregivers experience their involvement in rehabilitation care before proceeding to a larger trial to validate these findings.

Our final secondary objective was evaluated within a subgroup of patients recruited from inpatient care. We hypothesised that active caregiver involvement and provision of blended care support would smooth the care transition to the community by improving preparedness for discharge and reducing length of stay.¹³ We found no evidence to support our hypotheses with no significant differences in dyads’ preparedness for discharge. We did observe an important non-significant difference of 1 week in length of stay favouring the Armed4Stroke group, which could potentially reduce costs of care. The lack of significant effects may be explained by variation in length of stay between settings and patients corresponding to the relatively high standard deviations observed. Although these findings should be interpreted with caution, we recommend that future trials are sufficiently powered and include an economic evaluation to explore this further.

This study reports findings from a multicentre, randomised controlled trial with a rigorous study design, and the selection of outcome measures follows international consensus statements.²⁸ However, several study limitations should be acknowledged. First, this study is underpowered as a result of COVID-19 restrictions. We observed some positive trends on secondary outcome measures, namely, the functional ambulation categories, modified Ranking Scale and Nottingham Extended ADL leisure scale after 8 weeks. At 6 months, a trend was observed towards better perceived recovery and patients’ self-efficacy. However, these trends show considerable variability and should be interpreted with caution. Second, our primary outcome measure may suffer from a ceiling effect and may be insufficiently sensitive to quantify change in mild stroke patients.²⁹ Future mobility-directed studies should consider 6 min walking distance or 10 m comfortable walking speed measurement as a primary outcome measure. Third, a significantly higher proportion of lacunar strokes was seen in the intervention group. These patients may have had a slight prognostic advantage, but may also have suffered more from a ceiling effect. Fourth, patients were recruited at arbitrary time points poststroke, which could have resulted in a type II error. Fifth, our patients were relatively young and mostly recruited from inpatient clinics, limiting generalizability to other settings. However, diversity in ethnic background and gender in this sample supports the external validity. Finally, further investigation is required to study the long-term effects of our program. Clinical message

The Armed4Stroke program did not result in improved self-reported mobility.

Involving caregivers in task-specific training did not lead to a higher perceived burden compared to usual care.

Involvement of caregivers in rehabilitation may improve caregivers’ psychosocial wellbeing.

Footnotes

Acknowledgements

We would like to thank all patients, informal caregivers and staff involved in recruitment and treatment in the participating centres. Thank you for dedicating your time and efforts and for staying motivated during the pandemic, a particularly difficult time to run a trial, treat patients, involve caregivers and experience the consequences of stroke. We would specifically like to thank Esther Kret, Judith Vloothuis, Frank Berenpas, Lianne de Langen, Peter Elich, Judith Fleuren, René Brunsveld, Nancy Brookhuis, Michelle Bernhardi, Nanny Steinmeijer, Nelleke Kooiman and Josien Kosse for their valuable input, energy and motivation. In addition, we would like to thank Birgit Lissenberg-Witte from the epidemiology and data science department of the Amsterdam UMC for her statistical support during our unplanned interim analysis. Finally, we would like to thank our interns Evi Dekker and Jet Kruithof who provided invaluable support in recruiting our final patients and preparing our dataset for analyses.

Author Contributions

All authors conceived the study and were involved in protocol development. GK was penwriter, applied and received funding and RN gained ethical approval. MM and CN were involved in patient recruitment. MM analysed the data and wrote the first draft of the manuscript. CN, EP, RN, JB, GK and EW made a substantial contribution to the analysis and interpretation of data. All authors reviewed and edited the manuscript and approved the final version.

Declaration of Conflicting Interests

The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Funding

The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work was supported by the Armed4Stroke project (grant number: 858001102) funded by the Royal Dutch Society for Physiotherapy Scientific College Physiotherapy (KNGF-WCF)/Netherlands Organisation for Health Research and Development (ZonMw). WCF and ZonMw had no role in the design of the study, collection and analysis of data, or in the preparation of the current manuscript.

ORCID iD

Marijn Mulder

References

Bohannon

Andrews

Smith

. Rehabilitation goals of patients with hemiplegia. Int J Rehabil Res 1988; 11: 181–184.

Sommerfeld

Von Arbin

. Disability test 10 days after acute stroke to predict early discharge home in patients 65 years and older. Clin Rehabil 2001; 15: 528–534.

Kennedy

Bernhardt

Churilov

, et al. Factors associated with time to independent walking recovery post-stroke. J Neurol Neurosurg Psychiatry 2021; 92: 702–708.

Paolucci

Grasso

Antonucci

, et al. Mobility status after inpatient stroke rehabilitation: 1-year follow-up and prognostic factors. Arch Phys Med Rehabil 2001; 82: 2–8.

Port

IVD

Kwakkel

Wijk

, et al. Susceptibility to deterioration of mobility long-term after stroke. A prospective cohort study. Stroke 2006; 37: 167–171.

Veerbeek

Koolstra

Ket

, et al. Effects of augmented exercise therapy on outcome of gait and gait-related activities in the first 6 months after stroke: a meta-analysis. Stroke 2011; 42: 3311–3315.

French

Thomas

Coupe

, et al. Repetitive task training for improving functional ability after stroke. Cochrane Database Syst Rev 2016; 11: CD006073.

Lohse

Lang

Boyd

. Is more better? Using metadata to explore dose–response relationships in stroke rehabilitation. Stroke 2014; 45: 2053–2058.

Intercollegiate Stroke Working Party. National clinical guideline for stroke for the United Kingdom and Ireland. London: Royal College of Physicians, 2023. www.strokeguidelines.org .

10.

Clarke

Burton

Tyson

, et al. Why do stroke survivors not receive recommended amounts of active therapy ? Findings from the ReAcT study, a mixed-methods case-study evaluation in eight stroke units. Clin reh 2018; 32: 1119–1132.

11.

Vloothuis

Mulder

Veerbeek

, et al. Caregiver-mediated exercises for improving outcomes after stroke. Cochrane Database Syst Rev 2016; 12: CD011058.

12.

Brouns

Meesters

JJL

Wentink

, et al. Why the uptake of eRehabilitation programs in stroke care is so difficult—a focus group study in the Netherlands. Implement Sci 2018; 13: 1–11.

13.

Mulder

Nikamp

Nijland

, et al. Can telerehabilitation services combined with caregiver-mediated exercises improve early supported discharge services poststroke? A study protocol for a multicentre, observer-blinded, randomized controlled trial. BMC Neurol 2022; 22: 1–10.

14.

Schulz

Altman

Moher

, for the CONSORT group. CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials. BMC Med 2010; 8.

15.

World Health Organization. Stroke–1989. Recommendations on stroke prevention, diagnosis, and therapy. Report of the WHO task force on stroke and other cerebrovascular disorders. Stroke 1989; 20: 1407–1431.

16.

English

Ceravolo

Dorsch

, et al. Telehealth for rehabilitation and recovery after stroke: state of the evidence and future directions. Int J Stroke 2022; 17: 487–493.

17.

Veerbeek

van Wegen

van Peppen

, et al. KNGF-richtlijn beroerte. Koninklijk Nederlands Genootschap voor Fysiotherapie 2017; section F: 26–48. www.kngf.nl/kennisplatform/richtlijnen/beroerte .

18.

Duncan

Bode

Lai

, et al. Rasch analysis of a new stroke-specific outcome scale: the stroke impact scale. Arch Phys Med Rehabil 2003; 84: 950–963.

19.

DeMets

Gordon

. Interim analysis: the alpha spending function approach. Statis 1994; 13: 1341–1352.

20.

van den Berg

Crotty

Liu

, et al. Early supported discharge by caregiver-mediated exercises and e-health support after stroke: a proof-of-concept trial. Stroke 2016; 47: 1885–1892.

21.

Vloothuis JDM Mulder

Nijland

RHM

, et al. Caregiver-mediated exercises with e-health support for early supported discharge after stroke (CARE4STROKE): a randomized controlled trial. PLoS One 2019; 14: e0214241.

22.

Kalra

Evans

Perez

, et al. Training carers of stroke patients: randomised controlled trial. Br Med J 2004; 328: 1099.

23.

Lindley

Anderson

Billot

, et al. Family-led rehabilitation after stroke in India (ATTEND): a randomised controlled trial. Lancet 2017; 390: 588–599.

24.

Galvin

Cusack

O’Grady

, et al. Family-mediated exercise intervention (FAME): evaluation of a novel form of exercise delivery after stroke. Stroke 2011; 42: 681–686.

25.

Everard

Luc

Doumas

, et al. Self-rehabilitation for post-stroke motor function and activity — a systematic review and meta-analysis. Neurorehabil Neural Repair 2021; 35: 1043–1058.

26.

English

Hillier

Lynch

. Circuit class therapy for improving mobility after stroke. Cochrane Database Syst Rev 2017; 6: CD007513.

27.

Yasmeen

Krewulak

Grant

, et al. The effect of caregiver-mediated mobility interventions in hospitalized patients on patient, caregiver, and health system outcomes: a systematic review. Arch Rehabil Res Clin Transl 2020; 2: 100053.

28.

Van Criekinge

Heremans

Burridge

, et al. Standardized measurement of balance and mobility post-stroke: consensus-based core recommendations from the third stroke recovery and rehabilitation roundtable. Int J Stroke 2024; 19: 158–168.

29.

Guidetti

Ytterberg

Ekstam

, et al. Changes in the impact of stroke between 3 and 12 months post-stroke, assessed with the stroke impact scale. J Rehabil Med 2014; 46: 963–968.

Allied rehabilitation using caregiver-mediated exercises combined with telerehabilitation for stroke (ARMed4Stroke): A randomised controlled trial

Abstract

Objective

Design

Setting

Participants

Intervention

Main measures

Results

Conclusions

Keywords

Introduction

Methods

Statistical Analyses

Results

Discussion

Footnotes

Acknowledgements

Author Contributions

Declaration of Conflicting Interests

Funding

ORCID iD

References